Expression and regulation of AC133 and CD133 in glioblastoma (Q39477380)

12 September 2017

title

Expression and regulation of AC133 and CD133 in glioblastoma (English)

1 reference

12 September 2017

author

Christel Herold-Mende

7

object named as

Christel Herold-Mende

0 references

Andreas Unterberg

5

object named as

Andreas Unterberg

0 references

author name string

Benito Campos

1

1 reference

12 September 2017

Lingcheng Zeng

2

1 reference

12 September 2017

Philip H Daotrong

3

1 reference

12 September 2017

Volker Eckstein

4

1 reference

12 September 2017

Heimo Mairbäurl

6

1 reference

12 September 2017

publication date

7 September 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

59

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

1974-1986

1 reference

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Insight into the complex regulation of CD133 in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Differentiation therapy exerts antitumor effects on stem-like glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Comparative analysis of in vitro conditions for rat adult neural progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Nomenclature of prominin-1 (CD133) splice variants - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Different angiogenic phenotypes in primary and secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Association of stem cell-related markers and survival in astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

AC133-2, a novel isoform of human AC133 stem cell antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21239

21 January 2018

Identifiers

DOI

10.1002/GLIA.21239

1 reference

12 September 2017

1 reference